Historical record - last NADAC effective date: 11/20/2019
Product Information
CITALOPRAM HBR 40 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.0355 per EA under NDC 65162005410. Its NADAC has been published 314 times since Nov 28, 2013.
FDA first approved this application on Nov 30, 2006.
Strength
40 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162005410
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/20/2019
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077289FDA Approved
11/30/2006
On Market Since
4/6/2010
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 40 MG TABLET has been published 314 times since Nov 28, 2013, and over the history we have for it it has declined 10.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0355 per EA |
|---|---|
| All-time high | $0.0464 (Feb 12, 2014) |
| All-time low | $0.0347 (Oct 23, 2019) |
| Median price | $0.0382 |
| Average price | $0.0386 |
| Largest weekly change | +10.2% (Jan 22, 2014) |
| Weeks tracked | 314 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-10.8%
Last surveyed Nov 27, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 40 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.0355 per EA (NDC 65162005410), effective Nov 27, 2019.
How has the price of CITALOPRAM HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 40 MG TABLET has declined 10.8%. It has been tracked across 314 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 40 MG TABLET?
Since Nov 28, 2013, the NADAC for CITALOPRAM HBR 40 MG TABLET has ranged from a low of $0.0347 (Oct 23, 2019) to a high of $0.0464 (Feb 12, 2014), with a median of $0.0382 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 40 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CITALOPRAM HBR 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CITALOPRAM HBR 40 MG TABLET?
CITALOPRAM HBR 40 MG TABLET (NDC 65162005410) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.